Updated: Oct 12
We're delighted to announce that Dr Christopher Martin, one of the original shareholders of Solcom (parent company of Whzan Digital Health), has been appointed to the Board of Directors as a non-executive Director.
Chris was one of the original shareholders in Solcom and still retains a significant shareholding today. Chris is Chief Executive of ADC Therapeutics, a Swiss-based drug development company focused on developing therapies for cancers, including lymphoma and small cell lung cancer.
ADCT listed on the New York Stock Exchange last year at a value of US$1,500,000,000. He is also Chairman of Tokamak Energy, a UK based company pioneering fusion energy. We're excited to bring his experience to the business, his appointment will strengthen our Board and contribute further to the success of the company.